Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-3304 with Chemo-radiation in Locally Advanced NSCLC
NCT00078390Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Feb 2003
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of S-3304 in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Shionogi & Co., Ltd. Primary endpoints: Maximum Tolerated Dose, Efficacy and 1 more. Started Feb 2003; status: completed.
02
Drugs
S-3304
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00078390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00078390.